» Authors » Ahmed A Elhadidy

Ahmed A Elhadidy

Explore the profile of Ahmed A Elhadidy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elsebaey M, Enaba M, Elashry H, Elbedewy T, El Nakib A, Elhadidy A, et al.
Medicina (Kaunas) . 2024 Aug; 60(8). PMID: 39202539
: Endoscopic biliary plastic stenting is a safe and effective temporary therapeutic modality used in various benign biliary disorders. Long-term indwelling stents for more than one year without retrieval are...
2.
Watany M, El-Horany H, Elhosary M, Elhadidy A
Mol Med . 2022 Dec; 28(1):147. PMID: 36476132
Background: Deregulated autophagy in diabetes has been a field of many experimental studies recently. Impaired autophagy in diabetic kidneys orchestrates every step of diabetic nephropathy (DN) pathogenesis. This study aimed...
3.
Elsebaey M, Elbedewy T, Elashry H, Elrefaey W, Elshweikh S, Elhadidy A, et al.
Medicine (Baltimore) . 2022 Dec; 101(47):e31962. PMID: 36451458
Risk of hepatitis B virus reactivation (HBVr) in patients with resolved HBV infection receiving immunosuppressive therapy has been a growing concern, particularly in the era of biological and targeted therapies....
4.
Elsebaey M, Elashry H, Elbedewy T, Elhadidy A, Esheba N, Ezat S, et al.
Medicine (Baltimore) . 2018 Apr; 97(16):e0403. PMID: 29668596
Acute upper gastrointestinal bleeding (UGIB) affects large number of elderly with high rates of morbidity and mortality. Early identification and management of the factors predicting in-hospital mortality might decrease mortality....
5.
Ahmed O, Elsebaey M, Fouad M, Elashry H, Elshafie A, Elhadidy A, et al.
Infect Drug Resist . 2018 Apr; 11:441-445. PMID: 29628768
Background And Aims: Treatment of hepatitis C virus (HCV) changed dramatically with the introduction of oral direct-acting antiviral drugs due to their high antiviral potency and safety profile. Sofosbuvir plus...